FDA approved first biosimilar for the treatment of certain breast and stomach cancers
On Dec. 1, 2017, the U.S. Food and Drug Administration (FDA) approved Mylan’s Ogivri (trastuzumab-dkst) as a biosimilar…
On Dec. 1, 2017, the U.S. Food and Drug Administration (FDA) approved Mylan’s Ogivri (trastuzumab-dkst) as a biosimilar…
On Nov. 16, 2017, the the U.S. Food and Drug Administration (FDA) approved the Genentech drug Hemlibra (emicizumab-kxwh)…
On Nov. 16, 2017, Columbia University and NewYork-Presbyterian announced that Florence Irving and her late husband, Herbert Irving,…
On Nov. 3, 2017, construction started on the Calgary Cancer Centre located at the northeast corner of the…
On Oct. 18, 2017, the Siteman Cancer Center became one of the first cancer centers nationwide to offer…
On Sept. 20, 2017, resarchers at deCODE genetics use whole-genome data from 14,000 people from across the population…
On Aug. 24, 2017, Adamas announced U.S. Food and Drug Administration (FDA) approval of GOCOVRI as First and…
On Aug. 16, 2017, the Cancer Prevention and Research Institute of Texas (CPRIT) awarded 60 new academic research,…
On Aug. 15, 2017, the National Institutes of Health’s (NIH) Gabriella Miller Kids First Pediatric Research Program awarded…
On Jul. 13, 2017, the Defense Advanced Research Projects Agency (DARPA) awarded UC Berkeley $21.6 million over four…
On Jul 6, 2017, a group led by virologist David Evans of the University of Alberta in Edmonton,…
On May 23, 2017, the University of Chicago Medicine announced receipt of a $100 million donation by Craig…
On May 19, 2017, the U.S. Centers for Disease Control and Prevention (CDC) published Immunization Practices Advisory Committee…
On May 10, 2017, Siteman Cancer Center met the standards of the American Society for Radiation Oncology (ASTRO)…
On May 3, 2017, the University of Pennsylvania announced plans to build a $1.5 billion new hospital on…
On Apr. 26, 2017, the University of Virginia Cancer Center was honored as one of just 69 National…
On Apr. 21, 2017, the U.S. Centers for Disease Control and Prevention (CDC) published updated guidelines for use…
On Feb. 16, 2017, the new Cleveland Clinic Taussig Cancer Center began welcoming patients. The 377,000-square-foot facility, estimated…
On Jan. 23, 2017, Jeffrey and Patricia Cole donated $2.25 million to Cleveland Clinic Florida Tomsich Health and…
On Jan. 19, 2017, PharmAthene and Altimmune, a privately-held immunotherapeutics company targeting infectious diseases, announced an agreement for…
In 2017, SpringWorks Therapeutics was founded in Stamford, Connecticut, as a clinical-stage biopharmaceutical company that applies a precision…
In 2017, Virginia Tech veterinary pathologist Kevin Lahmers identified the Asian longhorned tick as the source of seven…
On Dec. 14, 2016, Medigen Vaccine Biologics (MVC) amended an existing agreement with the National Institutes of Health…
On Dec. 3, 2016, Celgene, Dana-Farber Cancer Institute and the University of Arkansas for Medical Sciences announced the…
On Nov. 18, 2016, Washington University in St. Louis launched a bold, $25 million initiative over the next…
On Nov. 17, 2016, the U.S. Surgeon General Dr. Vivek Murthy issued a landmark Report on Alcohol, Drugs,…
On Nov. 15, 2016, the National Institutes of Health (NIH) issued guidelines for DNA splicing. The guidelines set…
On Nov. 4, 2016, the U.S. Centers for Disease Control and Prevention’s (CDC) Immunization Practices Advisory Committee (ACIP)…
On Oct. 18, 2016, the U.S. Food and Drug Administration (FDA) approved TECENTRIQ® (atezolizumab) for the treatment of…
On Oct. 13, 2016, the Cell Atlas Initiative was launched at a meeting at The Wellcome Trust in…